Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A Final Report on 60 Cases

Mario Airoldi; Massimiliano GARZARO; Fulvia Pedani; Oliviero Ostellino; Giovanni Succo; Giuseppe Riva; Matteo Sensini; Nertila Naqe; Elisa Bellini; Luca Raimondo; Giancarlo Pecorari

doi:10.1097/COC.0000000000000112

Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A Final Report on 60 Cases

Mario Airoldi
, Massimiliano GARZARO
, Fulvia Pedani
, Oliviero Ostellino
, Giovanni Succo
, Giuseppe Riva
, Matteo Sensini
, Nertila Naqe
, Elisa Bellini
, Luca Raimondo
, Giancarlo Pecorari

Department of Health Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

Recurrent or metastatic salivary gland malignancies (RMSGM) are not suitable for conventional treatment. We report the clinical outcomes of 60 patients affected by RMSGM who were treated with DDP+VNB as a first-line or second-line scheme.

Original language	English
Pages (from-to)	86-90
Number of pages	5
Journal	American Journal of Clinical Oncology: Cancer Clinical Trials
Volume	40
Issue number	1
DOIs	https://doi.org/10.1097/COC.0000000000000112
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Squamous Cell
Cisplatin
Female
Head and Neck Neoplasms
Humans
Male
Middle Aged
Neoplasm Recurrence, Local
Prospective Studies
Salivary Gland Neoplasms
Treatment Outcome
Vinblastine
Young Adult

Access to Document

10.1097/COC.0000000000000112

http://hdl.handle.net/11579/94838

Cite this

Airoldi, M., GARZARO, M., Pedani, F., Ostellino, O., Succo, G., Riva, G., Sensini, M., Naqe, N., Bellini, E., Raimondo, L., & Pecorari, G. (2017). Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A Final Report on 60 Cases. American Journal of Clinical Oncology: Cancer Clinical Trials, 40(1), 86-90. https://doi.org/10.1097/COC.0000000000000112

@article{a5879f5ea1624209ba4de3a8a131bbbb,

title = "Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A Final Report on 60 Cases",

abstract = "Recurrent or metastatic salivary gland malignancies (RMSGM) are not suitable for conventional treatment. We report the clinical outcomes of 60 patients affected by RMSGM who were treated with DDP+VNB as a first-line or second-line scheme.",

keywords = "Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Squamous Cell, Cisplatin, Female, Head and Neck Neoplasms, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Prospective Studies, Salivary Gland Neoplasms, Treatment Outcome, Vinblastine, Young Adult, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Squamous Cell, Cisplatin, Female, Head and Neck Neoplasms, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Prospective Studies, Salivary Gland Neoplasms, Treatment Outcome, Vinblastine, Young Adult",

author = "Mario Airoldi and Massimiliano GARZARO and Fulvia Pedani and Oliviero Ostellino and Giovanni Succo and Giuseppe Riva and Matteo Sensini and Nertila Naqe and Elisa Bellini and Luca Raimondo and Giancarlo Pecorari",

year = "2017",

doi = "10.1097/COC.0000000000000112",

language = "English",

volume = "40",

pages = "86--90",

journal = "American Journal of Clinical Oncology: Cancer Clinical Trials",

issn = "0277-3732",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

Airoldi, M, GARZARO, M, Pedani, F, Ostellino, O, Succo, G, Riva, G, Sensini, M, Naqe, N, Bellini, E, Raimondo, L & Pecorari, G 2017, 'Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A Final Report on 60 Cases', American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 40, no. 1, pp. 86-90. https://doi.org/10.1097/COC.0000000000000112

TY - JOUR

T1 - Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A Final Report on 60 Cases

AU - Airoldi, Mario

AU - GARZARO, Massimiliano

AU - Pedani, Fulvia

AU - Ostellino, Oliviero

AU - Succo, Giovanni

AU - Riva, Giuseppe

AU - Sensini, Matteo

AU - Naqe, Nertila

AU - Bellini, Elisa

AU - Raimondo, Luca

AU - Pecorari, Giancarlo

PY - 2017

Y1 - 2017

N2 - Recurrent or metastatic salivary gland malignancies (RMSGM) are not suitable for conventional treatment. We report the clinical outcomes of 60 patients affected by RMSGM who were treated with DDP+VNB as a first-line or second-line scheme.

AB - Recurrent or metastatic salivary gland malignancies (RMSGM) are not suitable for conventional treatment. We report the clinical outcomes of 60 patients affected by RMSGM who were treated with DDP+VNB as a first-line or second-line scheme.

KW - Adult

KW - Aged

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Carcinoma, Squamous Cell

KW - Cisplatin

KW - Female

KW - Head and Neck Neoplasms

KW - Humans

KW - Male

KW - Middle Aged

KW - Neoplasm Recurrence, Local

KW - Prospective Studies

KW - Salivary Gland Neoplasms

KW - Treatment Outcome

KW - Vinblastine

KW - Young Adult

KW - Adult

KW - Aged

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Carcinoma, Squamous Cell

KW - Cisplatin

KW - Female

KW - Head and Neck Neoplasms

KW - Humans

KW - Male

KW - Middle Aged

KW - Neoplasm Recurrence, Local

KW - Prospective Studies

KW - Salivary Gland Neoplasms

KW - Treatment Outcome

KW - Vinblastine

KW - Young Adult

UR - https://iris.uniupo.it/handle/11579/94838

U2 - 10.1097/COC.0000000000000112

DO - 10.1097/COC.0000000000000112

M3 - Article

SN - 0277-3732

VL - 40

SP - 86

EP - 90

JO - American Journal of Clinical Oncology: Cancer Clinical Trials

JF - American Journal of Clinical Oncology: Cancer Clinical Trials

IS - 1

ER -

Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A Final Report on 60 Cases

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this